Pegcetacoplan: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Pegcetacoplan. Educational only — not medical advice.

Labeled uses

SYFOVRE is indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Source: FDA labeling via NIH DailyMed (set b4434e61…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.